Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-08-29
1999-11-02
Feisee, Lila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 8, 514 13, 514 14, 514 15, 514 16, 514 17, 514 18, 514 19, A61K 3829
Patent
active
059770708
ABSTRACT:
A pharmaceutical composition for the nasal delivery of compounds useful for treating osteoporosis, comprising an effective amount of a physiologically active truncated analog of PTH or PTHrp, or salt thereof, in which amino acid residues (22-31) form an amphipathic .alpha.-helix, said residues (22-31) selected from (SEQ ID NOS: 85, 86, 26, 27, 28, 29, and 30); an absorption enhancer selected from the group consisting of dimethyl-.beta.-cyclodextrin and the bile acid surfactants; and water is provided.
REFERENCES:
patent: 4086196 (1978-04-01), Tregear
patent: 4423037 (1983-12-01), Rosenblatt et al.
patent: 4738921 (1988-04-01), Belagaje et al.
patent: 4771124 (1988-09-01), Rosenblatt et al.
patent: 4833125 (1989-05-01), Neer et al.
patent: 4835255 (1989-05-01), Weissman et al.
patent: 4861756 (1989-08-01), Jackson
patent: 4968669 (1990-11-01), Rosenblatt et al.
patent: 5001223 (1991-03-01), Rosenblatt et al.
patent: 5010010 (1991-04-01), Gautvik et al.
patent: 5087562 (1992-02-01), Rosenblatt et al.
patent: 5089482 (1992-02-01), Hermens
patent: 5093233 (1992-03-01), Rosenblatt et al.
patent: 5116952 (1992-05-01), Martin et al.
patent: 5149779 (1992-09-01), Chorev et al.
patent: 5171670 (1992-12-01), Kronenberg et al.
patent: 5183802 (1993-02-01), Aliverti et al.
patent: 5229489 (1993-07-01), Kanmera et al.
patent: 5317010 (1994-05-01), Pang et al.
patent: 5382658 (1995-01-01), Kronis et al.
patent: 5393869 (1995-02-01), Nakagawa et al.
patent: 5434246 (1995-07-01), Fukuda et al.
patent: 5589452 (1996-12-01), Krstenansky
patent: 5807823 (1998-09-01), Krstenansky
patent: 5821225 (1998-10-01), Vickery
Schulz and Schirmer, Principles of protein structure, pp. 69-70, 1979.
Chorev, et al., "First highly potent cyclic parathyroid hormone-related peptide (PTHrP) antagonist", Peptides (1990) pp. 736-737.
Biochem., (1974), vol. 13, No. 9, pp. 1994-2000, R.T. Sauer et al. The Amino Acid Sequence of Porcine Parathyroid Hormones.
J. of Bone and Mineral Res., (1992), vol. 7, No. 1, pp. 65-72, J.M. Hock et al. Effects of Continuous and Intermittent Administration and Inhibition of Resorption on the Anabolic Response of Bone to Parathyroid Hormone.
Clin. Science, (1982), vol. 62, pp. 389-396, E. Hefti et al. Increase of Whole-body Calcium and Skeletal Mass in Normal and Osteoporotic Adult Rats Treated with Parathyroid Hormone.
Metab. Bone Dis. & Rel. Res., (1984), vol. 5, pp. 177-181, M. Gunness-Hey et al. Increased Trabecular Bone Mass in Rats Treated with Human Synthetic Parathyroid Homone.
J. of Bone & Mineral Res., (1991), vol. 6, No. 10, pp. 1071-1080, C.C. Liu et al. Preexisting bone Loss Associated with Ovariectomy in Rats is Reversed by Parathyroid Hormone.
Endocrinology, (1988), vol. 122, No. 6, pp. 2899-2904, J.M. Hock et al. Human Parathyroid Hormone-(1-34) Increases Bone Mass in Ovariectomized and Orchidectomized Rats.
Science, (1987), vol. 238, pp. 1566-1568, N. Horiuchi et al. Similarity of Synthetic Peptide from Human Tumor to Parathyroid Hormone in Vivo and in Vitro.
Science, (1987), vol. 238, pp. 1568-1570, B.E. Kemp et al. Parathyroid Hormone-Related Protein of Malignancy: Active Synthetic Fragments.
J. of Clin. Invest., (1987), vol. 80, pp. 1803-1807, G.J. Strewler et al. Parathyroid Hormonelike Protein from Human Renal Carcinoma Cells.
Proceedings of the Eleventh American Peptide Symposium, (1989). Second Generation of Potent Parathyroid Hormone (PTH) Antagonists.
J. of Biological Chem., (1991), vol. 266, No. 3, pp. 1997-2004, F.E. Cohen et al. Analogues of Parathyroid Hormone Modified at Positions 3 and 6.
Biophysical J., (1967), vol. 7, pp. 121-135, M. Schiffer et al. Use of Helical Wheels to Represent the Structures of Proteins and to Identify Segments with Helical Potentia.
Adv. Enzymol., (1978), vol. 47, pp. 45-147, P.Y. Chou et al. Prediction of the Secondary Structure of Proteins from Their Amino Acid Sequence.
J. of the Amer. Chem. Society, (1979), pp. 3703-3704, D. Fukushima et al. A Synthetic Amphiphilic Helical Docosapeptide with the Surface Properties of Plasma Apolipoprotein A-I.
Proc. Natl. Acad. Sci., (1980), vol. 77, No. 6, pp. 3154-3158, H.J. Pownall et al. Activation of Lecithin:Cholesterol Acyltransferase by a Synthetic Model Lipid-Associating Peptide.
J. of Bio. Chem., (1980), vol. 255, No. 23, pp. 11464-11472, P. Kanellis et al. Studies of Synthetic Peptide Analogs of the Amphipathic Helix.
Nature, (1982), vol. 299, pp. 371-374, D. Eisenberg et al. The Helical Hydrophobic Moment: A Measure of the Amphiphilicity of a Helix.
Science, (1984) vol. 223, pp. 249-255, E.T. Kaiser et al. Amphiphilic Secondary Structure: Design of Peptide Hormones.
Proc. Natl. Acad. Sci., (1984), vol. 81, pp. 140-144, D. Eisenberg et al. The Hydrophobic Moment Detects Periodicity in Protein Hydrophobicity.
J. of Bio. Chemistry, (1985), vol. 260, No. 18, pp. 10248-10255, G.M. Anantharamaiah et al. Studies of Synthetic Peptide Analogs of the Amphipathic Helix.
J. of Bio. Chemistry, (1985), vol. 260, No. 18, pp. 10256-10262, B.H. Chung et al. Studies of Synthetic Peptide Analogs of the Amphipathic Helix.
Int. J. Peptide Protein Res., (1985), vol. 25, pp. 594-600, R.M. Epand et al. Formation of Water-Soluble Complex Between the 1-34 Fragment of Parathyroid Homone and Dimyristoylphosphatidylcholine.
Proteins, (1986), vol. 1, pp. 16-22, D. Eisenberg et al. The Design, Synthesis and Crystallization of an Alpha-Helical Peptide.
Biochem., (1987), vol. 26, pp. 2964-2972, N.K. Subbarao et al. pH-Dependent Bilayer Destabilization by an Amphipathic Peptide.
J. of Bio. Chemistry, (1987), vol. 262, No. 19, pp. 9389-9396, R.M. Epand et al. Studies of Synthetic Peptide Analogs of the Amphipathic Helix.
J. Mol. Biol., (1987), vol. 195, pp. 659-685, J.L. Cornette et al. Hydrophobicity Scales and Computational Techniques for Detecting Amphipathic Structures in Proteins.
Int. J. Peptide Protein Res., (1988), vol. 32, pp. 468-475, J.L. Krstenansky et al. Importance of the C-terminal .alpha.-Helical Structure for Glucagon's Biological Activity.
FEBS Letters, (1989), vol. 242, No. 2, pp. 409-413, J.L. Krstenansky et al. Short Model Peptides Having a High .alpha.-Helical Tendency: Design and Solution Properties.
Science, (1989), vol. 243, pp. 622-628, W.F. Degrado et al. Protein Design, a Minimalist Approach.
Biophys. J., (1989), vol. 55, pp. 358a, J.L. Tuls et al. Stabilization of .alpha.-Helicity in Bovine Growth Hormone Fragments (abstract).
Proteins, (1989), vol. 6, pp. 61-69, J.G. Dohlman et al. Identification of Peptide Hormones of the Amphipathic Helix Class Using the Helical Hydrophobic Moment Algorithm.
Proteins,(1990), vol. 8, pp. 103-117, J.P. Segrest et al. Amphipathic Helix Motif: Classes and Properties.
Biochem., (1990), vol. 29, No. 8, pp. 2016-2022, L.R. McLean et al. Examination of the Role of the Amphipathic .alpha.-Helix in the Interaction of Neuropeptide Y and Active Cyclic Analogues with Cell Membrane Receptors and Dimyristoylphosphatidylcholine.
Biochem., (1991), vol. 30, No. 1, pp. 31-37, L.R. McLean et al. Minimal Peptide Length for Interaction of Amphipathic .alpha.-Helical Peptides with Phosphatidylcholine Liposomes.
Biophys. J., (1991), vol. 59, pp. 506a, L.R. McLean et al. Relationship Between Amphipathic .alpha.-Helical Protential in Peptides and Activity as Synthetic Lung Surfactants (abstract).
Biochimica et Biophysica Acta., (1991), vol. 1086, pp. 106-114, L.R. McLean et al. Examination of the Peptide Sequence Requirements for Lipid-Binding. Alternative Pathways for Promoting the Interaction of Amphipathic .alpha.-Helical Peptides with Phosphatidylcholine.
J. of Lipid Res., (1992), vol. 33, pp. 141-166, J.P. Segrest et al. The Amphipathic Helix in the Exchangeable Apolipoproteins: A Review of Secondary Structure and Function.
Gene, (1985), vol. 39, pp. 239-245, T. Kempe et al. Multiple-copy Genes: Production and Modification of Monomeric Peptides from Large Multimeric Fusion Proteins.
Bio/Technology, (1986), vol. 4, pp. 565-568, T. Kempe et al. Production and Characterization of Growth Hormone Releasing Factor Analogs Through Recombinant DNA and Chemical Techniques.
Bio/
Krstenansky John Leonard
Nestor, Jr. John Joseph
Piazza Christin Teresa
Radomsky Michael Lloyd
Vickery Brian Henry
Feisee Lila
Lazar-Wesley Eliane
LandOfFree
Pharmaceutical compositions for the nasal delivery of compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions for the nasal delivery of compounds , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions for the nasal delivery of compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2135520